223 related articles for article (PubMed ID: 25091126)
1. Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study.
Walker EJ; Ko AH; Holly EA; Bracci PM
Int J Cancer; 2015 Mar; 136(6):E646-53. PubMed ID: 25091126
[TBL] [Abstract][Full Text] [Related]
2. Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.
Kusturica J; Kulo Ćesić A; Gušić E; Maleškić S; Rakanović-Todić M; Šečić D
Med Glas (Zenica); 2017 Aug; 14(2):176-181. PubMed ID: 28698536
[TBL] [Abstract][Full Text] [Related]
3. Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging.
Wennberg AMV; Hagen CE; Edwards K; Roberts RO; Machulda MM; Knopman DS; Petersen RC; Mielke MM
Int J Geriatr Psychiatry; 2018 Aug; 33(8):1114-1120. PubMed ID: 29873112
[TBL] [Abstract][Full Text] [Related]
4. Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study.
Cardel M; Jensen SM; Pottegård A; Jørgensen TL; Hallas J
Cancer Med; 2014 Oct; 3(5):1458-66. PubMed ID: 25091592
[TBL] [Abstract][Full Text] [Related]
5. Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.
Allott EH; Abern MR; Gerber L; Keto CJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Moorman PG; Freedland SJ
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):391-7. PubMed ID: 24100644
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking and risk of pancreatic cancer: a clinic-based case-control study in the San Francisco Bay Area.
Lea CS; Holly EA; Bracci PM
Ann Epidemiol; 2015 Nov; 25(11):816-23. PubMed ID: 26475980
[TBL] [Abstract][Full Text] [Related]
7. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
Smiechowski BB; Azoulay L; Yin H; Pollak MN; Suissa S
Diabetes Care; 2013 Jan; 36(1):124-9. PubMed ID: 22923670
[TBL] [Abstract][Full Text] [Related]
8. Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Am J Gastroenterol; 2012 Apr; 107(4):620-6. PubMed ID: 22290402
[TBL] [Abstract][Full Text] [Related]
9. Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies.
Li D; Tang H; Hassan MM; Holly EA; Bracci PM; Silverman DT
Cancer Causes Control; 2011 Feb; 22(2):189-97. PubMed ID: 21104117
[TBL] [Abstract][Full Text] [Related]
10. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
Tseng CH
Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
[TBL] [Abstract][Full Text] [Related]
11. Metformin use and cervical cancer risk in female patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Sep; 7(37):59548-59555. PubMed ID: 27486978
[TBL] [Abstract][Full Text] [Related]
12. Multivitamin Use and Serum Vitamin B12 Concentrations in Older-Adult Metformin Users in REGARDS, 2003-2007.
Kancherla V; Garn JV; Zakai NA; Williamson RS; Cashion WT; Odewole O; Judd SE; Oakley GP
PLoS One; 2016; 11(8):e0160802. PubMed ID: 27513580
[TBL] [Abstract][Full Text] [Related]
13. Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study.
Walker EJ; Ko AH; Holly EA; Bracci PM
Cancer; 2015 Apr; 121(8):1287-94. PubMed ID: 25649483
[TBL] [Abstract][Full Text] [Related]
14. Metformin and Risk of Alzheimer's Disease Among Community-Dwelling People With Diabetes: A National Case-Control Study.
Sluggett JK; Koponen M; Bell JS; Taipale H; Tanskanen A; Tiihonen J; Uusitupa M; Tolppanen AM; Hartikainen S
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31778170
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic therapies affect risk of pancreatic cancer.
Li D; Yeung SC; Hassan MM; Konopleva M; Abbruzzese JL
Gastroenterology; 2009 Aug; 137(2):482-8. PubMed ID: 19375425
[TBL] [Abstract][Full Text] [Related]
16. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.
Donadon V; Balbi M; Casarin P; Vario A; Alberti A
World J Gastroenterol; 2008 Oct; 14(37):5695-700. PubMed ID: 18837086
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer.
Berstein LM; Iyevleva AG; Vasilyev D; Poroshina TE; Imyanitov EN
Cell Cycle; 2013 Dec; 12(23):3681-8. PubMed ID: 24145224
[TBL] [Abstract][Full Text] [Related]
18. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.
Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195
[TBL] [Abstract][Full Text] [Related]
19. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract][Full Text] [Related]
20. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
Hung SC; Chang YK; Liu JS; Kuo KL; Chen YH; Hsu CC; Tarng DC
Lancet Diabetes Endocrinol; 2015 Aug; 3(8):605-14. PubMed ID: 26094107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
